Dear Editor,

According to the principles of antimicrobial stewardship, avoiding inappropriate antibiotics administration is a strong strategy towards containing the development and diffusion of bacterial resistances. Westhoff et al. [1] prospectively evaluated the incidence of infectious complications after 145 insertions/exchanges of ureteral stents and nephrostomies in 99 patients. The Acute Cystitis Symptom Score (ACSS) questionnaire was used to evaluate urinary tract infection symptoms before procedure and 7 days after. 122 procedures were performed without antimicrobial prophylaxis or treatment, while in 23 procedures, an antibiotic treatment or prophylaxis was administrated. Asymptomatic bacteriuria was detected in 71 and 8 cases in the 2 groups, respectively. Overall, 3 procedures required antibiotic treatment for a symptomatic urinary tract infection, body temperature >37.5°C was recorded after 5 interventions, and 1 patient needed hospitalization. The authors did not find any statistically significant difference in infectious complication rates and ACSS results between procedures performed with or without antimicrobial prophylaxis or treatment. According to these results, it seems that presence of asymptomatic bacteriuria did not increase the risk of post-procedural infectious complications in this setting. Interestingly, ACSS questionnaire results demonstrated that transurethral procedures worsened lower urinary tract symptoms compared to percutaneous interventions, with no difference in terms of infectious complication rates between the 2 groups. This finding highlights the importance of identifying the origin of symptoms before administrating an antibiotic therapy. Given the knowledge gap on this topic, the study provides a message of clinical importance for the everyday clinical practice of many urologists. Interestingly, enough of the results of Niklas Westhoff et al. [1] are in line with our previous findings. Between 2018 and 2019, we prospectively evaluated the incidence of infectious complications in 39 patients undergoing routine office nephrostomy tube replacement performed without any antimicrobial prophylaxis. 126 procedures were analyzed [2].

We recorded 17 cases (13.5%) of infectious complications defined as fever ≥38°C. Eight patients did not require medical evaluation nor antibiotic treatment as fever resolved spontaneously, 8 cases were managed with an oral antimicrobial therapy and 1 patient required hospitalization and intravenous antimicrobial therapy. In our series, only a Charlson comorbidity index score ≥3 was significantly associated with the risk of developing infectious complications. According to these data, we underline that using antimicrobial prophylaxis before routine nephrostomy tube replacement may be a practice based on common habits not on evidences, whereas evidence sustaining that avoiding antimicrobial prophylaxis in this scenario does not expose patients to the risk of life threatening infectious complications actually exists. Nowadays, antimicrobial resistance is challenging our health care system [3, 4]. Currently available urological guidelines mainly refer to endourologic surgery [5, 6], while the utility of antimicrobial prophylaxis in patients undergoing nephrostomy tubes and ureteral stents insertion or replacement remains an understudied topic. Given the number of these procedures performed in the daily routine of every urology department worldwide, further studies producing evidence regarding proper antimicrobial use in this setting should be encouraged in order to avoid unnecessary use of these precious drugs and help preserving their power.

The authors have no conflicts of interest to declare.

No funding was requested.

Luca Ongaro and Michele Rizzo detected the publication and wrote the manuscript. Carlo Trombetta and Giovanni Liguori reviewed the manuscript. All authors approved the final version of the manuscript.

1.
Westhoff
N
,
Anokhin
A
,
Patroi
P
,
Neuberger
M
,
Siegel
F
,
Pfalzgraf
D
.
Prospective evaluation of antibiotic management in ureteral stent and nephrostomy interventions
.
Urol Int
.
2021 Jul
;
30
(
7
):
1
8
. .
2.
Rizzo
M
,
Ongaro
L
,
Claps
F
,
Cai
T
,
Umari
P
,
Bucci
S
,
An observational cohort study investigating the incidence rate of infectious complications after routine office nephrostomy tube replacement without using antimicrobial prophylaxis
.
Urology
.
2021 Jan
;
147
(
1
):
27
32
.
3.
Wolf
J
.
Antibiotic resistance threatens the efficacy of prophylaxis
.
Lancet Infect Dis
.
2015 Dec
;
15
(
12
):
1368
9
. .
4.
Manseck
AS
,
Otto
W
,
Schnabel
M
,
Denzinger
S
,
Burger
M
,
Spachmann
PJ
.
Geriatric patients and symptomatic urinary tract infections: analysis of bacterial range and resistance rates at a 3rd level of care hospital in Germany
.
Urol Int
.
2021 Jun
;
25
(
6
):
1
6
. .
5.
Dasgupta
R
,
Grabe
M
.
Preoperative antibiotics before endourologic surgery: current recommendations
.
J Endourol
.
2009 Oct
;
23
(
10
):
1567
70
. .
6.
Bonkat
G
,
Bartoletti
R
,
Bruyere
F
,
Cai
T
,
Geerlings
SE
,
Köves
B
,
Guidelines on urological infections
.
European Association of Urology
;
2021
. Available from: https://uroweb.org/guideline/urological-infections.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.